Chatbots Battle COVID-19 Vaccine Hesitancy

This article originally appeared on the Johns Hopkins University website. Below is a brief excerpt.

As COVID-19 vaccines were still racing through clinical trials, a team at Johns Hopkins University developed VIRA, the Vaccine Information Resource Assistant. The chatbot debuted first as a webpage in July 2021, and later, with the marketing and technical support of Meta (previously Facebook), as a WhatsApp version this past January. The app is currently available in the U.S. in both English and Spanish, and the team is building international models.

Responding immediately to user questions, VIRA offers concise, plainspoken, expert-vetted answers to questions about COVID-19 vaccines, linking to trusted sources for further information.

Learn how the VIRA chatbot has been helping combat vaccine hesitancy.

You May Also Like

Delivering 270M+ COVID-19 vaccines at just $0.29 per dose: The Bangladesh experience

Bangladesh launched its COVID-19 vaccination program in February 2021 with the ambitious aim of reaching 80% of the population with two doses. The program used a phased approach, initially targeting priority groups, and expanding eligibility over time as supply ramped up. By June 2022, the country had achieved its goal—having delivered over 270 million COVID-19 … Read More

New evidence on the costing the delivery of COVID-19 vaccines in Mozambique and the Philippines

ThinkWell has released two new reports on the cost of delivering COVID-19 vaccines in Mozambique and the Philippines, aiming to support governments and address the knowledge gap on the cost of these vaccination programs. In partnership with the Universidade Eduardo Mondlane and Ateneo de Manila University, ThinkWell conducted retrospective, bottom-up costing studies, as well as … Read More